Evidence map›Paper›PMID 36307100›Full record

ArticleThrombosis and haemostasis2023

Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.

Liina Mochizuki, Hideto Sano, Naoki Honkura, Kazuma Masumoto, Tetsumei Urano, Yuko Suzuki

Open access · hybridAbstract read
In one paragraph

Article in Thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liina MochizukiDepartment of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hideto SanoDepartment of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Naoki HonkuraDepartment of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kazuma MasumotoDepartment of Dentistry and Oral and Maxillofacial Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Tetsumei UranoDepartment of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yuko SuzukiDepartment of Medical Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan.ORCID 0000-0003-4833-8580
Hamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThrombomodulin (TM) functions as a dual modulator-anticoagulant and antifibrinolytic potential-by the thrombin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI). Activated TAFI cleaves the C-terminal lysine of partially degraded fibrin and inhibits both plasminogen binding and its activation on the fibrin surface. We have reported previously that activated platelets initiate fibrin network formation and trigger fibrinolysis after the accumulation of tissue-type plasminogen activator and plasminogen.

objectiveTo analyze the effects of domain-deletion variants of TM on coagulation and fibrinolysis at different concentrations.

methodsDomain-deletion variants of TM, such as D123 (all extracellular regions), E3456 (minimum domains for thrombin-dependent activation of protein C and TAFI), and E456 (minimum domains for that of protein C but not TAFI), were used at 0.25 to 125 nM for turbidimetric assay to determine the clotting time and clot lysis time and to visualize fibrin network formation and lysis in platelet-containing plasma. RESULTS AND

conclusionsA low concentration of either D123 or E3456, but not of E456, prolonged clot lysis time, and delayed the accumulation of fluorescence-labeled plasminogen at the activated platelets/dense fibrin area due to effective TAFI activation. Conversely, only the highest concentrations of all three TM variants delayed the clotting time, though fibrin network formation in the vicinity of activated platelets was almost intact. TAFI activation might be affected by attenuation in thrombin activity after the clot formation phase. These findings suggest that the spatiotemporal balance between the anticoagulant and antifibrinolytic potential of TM is controlled in domain- and concentration-dependent manners.

Indexed as

Antifibrinolytic AgentsCarboxypeptidase B2AnticoagulantsFibrinFibrin Clot Lysis TimeFibrinolysisHumansPlasminogenProtein CThrombinThrombomodulinAnticoagulantsAntifibrinolytic AgentsCarboxypeptidase B2FibrinPlasminogenProtein CThrombinThrombomodulin

Identifiers

PMID36307100
PMCPMC9831690
OpenAlexW4307580791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.